Lv11
30 积分 2023-02-28 加入
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
15天前
已完结
Gemcitabine versus Bacillus Calmette-Guerin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
1个月前
已完结
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment
1个月前
已完结
Intravesikale Therapie des nicht muskelinvasiven Urothelkarzinoms der Harnblase
1个月前
已完结
[Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China (2024 edition)]
1个月前
已完结
Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; A comparative analysis of prediction models for recurrence and progression, including external validation of the updated 2021 E.A.U. model
1个月前
已完结
Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort
1个月前
已完结
American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation—Should Patient Age be Added to the Risk Model?
1个月前
已完结
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer
1个月前
已完结
Review of BCG immunotherapy for bladder cancer
1个月前
已完结
皖公网安备34019202002308
